SEC Form 4 · accession 0001179110-19-001440
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin P Sutter
Director
Period of report
Feb 4, 2019
Accepted (ET)
Feb 6, 2019 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF2 | Feb 4, 2019 | S | 17,548 | $350.1161 | D | 212,943 | D | |
| Common Stock, $0.01 par valueF3 | Feb 4, 2019 | S | 2,395 | $351.4563 | D | 210,548 | D | |
| Common Stock, $0.01 par valueF4 | Feb 5, 2019 | S | 4,072 | $350.0467 | D | 206,476 | D | |
| Common Stock, $0.01 par value | Feb 6, 2019 | S | 616 | $345.00 | D | 205,860 | D | |
| Common Stock, $0.01 par value | Feb 6, 2019 | S | 5,369 | $350.00 | D | 200,491 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.67 | holding | — | — | — | Aug 11, 2010 | Aug 12, 2019 | Common Stock | 12,000 | 12,000 | D |
| Stock Option (right to buy)F1 | $9.99 | holding | — | — | — | Aug 10, 2011 | Aug 11, 2020 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F2This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $350.0000 and $350.9700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F3This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $351.0100 and $351.9900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F4This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $350.0000 and $350.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.